1. Effect of FosPeg® mediated photoactivation on P-gp/ABCB1 protein expression in human nasopharyngeal carcinoma cells.
- Author
-
Wu RWK, Chu ESM, Huang Z, Xu CS, Ip CW, and Yow CMN
- Subjects
- ATP Binding Cassette Transporter, Subfamily B genetics, ATP Binding Cassette Transporter, Subfamily B metabolism, Carcinoma, Cell Line, Tumor, Drug Resistance, Neoplasm drug effects, Gene Expression Regulation radiation effects, Humans, Light, Liposomes chemistry, Liposomes therapeutic use, Mesoporphyrins chemistry, Mesoporphyrins therapeutic use, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms drug therapy, Nasopharyngeal Neoplasms metabolism, Nasopharyngeal Neoplasms pathology, Photochemotherapy, Photosensitizing Agents chemistry, Photosensitizing Agents therapeutic use, RNA, Messenger metabolism, Gene Expression Regulation drug effects, Liposomes pharmacology, Mesoporphyrins pharmacology, Photosensitizing Agents pharmacology
- Abstract
Multidrug resistance (MDR) refers to the ability of cancer cells to develop cross resistance to a range of anticancer drugs which are structurally and functionally unrelated. P-glycoprotein (P-gp) is the best studied MDR phenotype in photodynamic therapy (PDT) treated cells. Our pervious study demonstrated that FosPeg® mediated PDT is effective to NPC cell line models. In this in vitro study, the expression of MDR1 gene and its product P-gp in undifferentiated, poorly differentiated and well differentiated human nasopharyngeal carcinoma (NPC) cells were investigated. The influence of P-gp efflux activities on photosensitizer FosPeg® was also examined. Regardless of the differentiation status, PDT tested NPC cell lines all expressed P-gp protein. Results indicated that FosPeg® photoactivation could heighten the expression of MDR1 gene and P-gp transporter protein in a dose dependent manner. Up to 2-fold increase of P-gp protein expression were seen in NPC cells after FosPeg® mediated PDT. Interestingly, our finding demonstrated that FosPeg® mediated PDT efficiency is independent to the MDR1 gene and P-gp protein expression in NPC cells. FosPeg® itself is not the substrate of P-gp transporter protein and no efflux of FosPeg® were observed in NPC cells. Therefore, the PDT efficiency would not be affected even though FosPeg® mediated PDT could induce MDR1 gene and P-gp protein expression in NPC cells. FosPeg® mediated PDT could be a potential therapeutic approach for MDR cancer patients., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF